Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Matthew Xu

DPhil Student

Research interest:

My research focuses on developing next-generation cancer vaccines, specifically targeting EBV-associated malignancies and Chronic Lymphocytic Leukemia. I am interested in the full preclinical pipeline—from the strategic design of vaccine constructs to their validation in laboratory models. By integrating immunology and translational insights, I aim to develop effective strategies for late-stage and relapsing cancers, with the ultimate goal of managing advanced disease as a controllable chronic condition.

Background:

My fascination with immunology began through earlier research into autoimmune diseases, which sparked a lasting curiosity about the immune system's complexity. Before beginning my DPhil, I completed my medical degree followed by standardized residency training in traditional Chinese medicine, providing me with a pragmatic, patient-centered perspective on disease. I later

transitioned into a research master’s degree to bridge the gap between clinical observation and experimental science.

Moving forward, I hope to serve as a physician-scientist, ensuring my research remains deeply rooted in clinical significance to address the unmet medical needs of cancer patients